Development and validation of a prognostic immunoinflammatory index for patients with gastric cancer

Figure 1 Kaplan–Meier curves for progression-free survival. A: Progression-free survival (PFS) by CD3(+) lymphocytes; B: PFS by CD3(+)CD8(+) lymphocytes; C: PFS by CD4(+)CD8(+) lymphocytes; D: PFS by CD3(+)CD16(+)CD56(+) lymphocytes; E: PFS by CD19(+) lymphocytes; F: PFS by platelet-to-lymphocyte ratio; G: PFS by neutrophil-to-lymphocyte ratio; H: PFS by systemic immune inflammatory index; I: PFS by systemic inflammation response index. PLR: Platelet-to-lymphocyte ratio; NLR: Neutrophil-to-lymphocyte ratio; SII: Systemic immune inflammatory index; SIRI: Systemic inflammation response index; PFS: Progression-free survival.